Claus Rödel

Active 1998–2025

125
Papers
29,472
Citations
76
h-index
122
i10-index

Citations

Citations per year for Claus Rödel1979: 2 citations1980: 1 citations1983: 1 citations1990: 1 citations1995: 2 citations1998: 1 citations1999: 4 citations2000: 7 citations2001: 9 citations2002: 21 citations2003: 27 citations2004: 34 citations2005: 79 citations2006: 111 citations2007: 114 citations2008: 112 citations2009: 120 citations2010: 117 citations2011: 142 citations2012: 151 citations2013: 131 citations2014: 176 citations2015: 168 citations2016: 130 citations2017: 196 citations2018: 166 citations2019: 766 citations2020: 937 citations2021: 821 citations2022: 630 citations2023: 422 citations2024: 784 citations2025: 333 citations2026: 13 citations1981–1982: no citations, so these years are not shown1984–1989: no citations, so these years are not shown1991–1994: no citations, so these years are not shown1996–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,292 citing papers, 18.2% of this breakdownChina: 887 citing papers, 12.5% of this breakdownGermany: 640 citing papers, 9% of this breakdownUnited Kingdom: 475 citing papers, 6.7% of this breakdownItaly: 400 citing papers, 5.6% of this breakdownNetherlands: 374 citing papers, 5.3% of this breakdownFrance: 265 citing papers, 3.7% of this breakdownJapan: 231 citing papers, 3.3% of this breakdownSpain: 213 citing papers, 3% of this breakdownCanada: 193 citing papers, 2.7% of this breakdownSouth Korea: 167 citing papers, 2.4% of this breakdownSweden: 144 citing papers, 2% of this breakdown
0%18.2%Other 25.6%

Fields

  • Medicine83.5%
  • Biochemistry, Genetics and Molecular Biology10.6%
  • Immunology and Microbiology2.3%
  • Physics and Astronomy0.9%
  • Engineering0.9%
  • Computer Science0.5%
  • Other1.3%

Topics

  • Colorectal Cancer Surgical Treatments15.6%
  • Colorectal and Anal Carcinomas10.4%
  • Radiomics and Machine Learning in Medical Imaging4.2%
  • Colorectal Cancer Treatments and Studies3.7%
  • Colorectal Cancer Screening and Detection3.6%
  • Cancer Immunotherapy and Biomarkers3.4%
  • Other59.1%

Coauthors

All papers

Open in search
  1. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , - Annals of Oncology 2017 cited by 2,045

  2. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 cited by 325

  3. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2010 cited by 1,952

  4. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 6,065

  5. Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 2,118

  6. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin‐Leo Hansmann, Peter J. Wild, Stephan Falk, Petra Hödl, A Serebrennikov, Sanja Schmeck, Vittorio Paolucci, Stephan Sahm, Martin Eichel, Giovanna Römer, W. Bank, Nicolas Moosmann, Jan Braess, P. Piso, Heinrich Wiesinger, Peter Kappl, Elisabeth Germer, Monika Warmuth‐Metz, Volker Kunzmann, Katica Krajinovic, Andreas Rosenwald, Thorsten Alexander Bley, Ulrich Stölzel, Manfred Dörne, L. Renziehausen, Joachim Boese-Land, Dietrich Meißner, D. Burchert, Olaf Dirsch, Jörg Olaf Habeck, Klaus Kirchhof, Christof Lamberti, B. J. Leibl, Andreas Gschwendtner, Godehard Lahmer, Marga Lang-Welzenbach, Werner Hohenberger, Thomas Kuhnt, Kirsten Papsdorf, Christian Wittekind, Christine Volkheimer, Frederik Wenz, Kirsten Merx, Stefan Post, Timo Gaiser, Ulrike Attenberger, Michael Geißler, Jörn Sträter, Helmut Gnann, Stefan Krämer, Michael Henke, Henning Schäfer, Philipp Manegold, Hannes Neeff, Peter Bronsert, Wolff Schmiegel, Michael Pohl, Christian Möllecken, Irenä us A. Adamietz, Richard Viehbahn, Andrea Tannapfel, Jens Freiberg‐Richter, Thorsten Jacobi, Wolfgang Wendt, Klaus Holzweißig, Thomas Kittner, Ullrich Graeven, Christiane Lange, U. Kania, Elisabeth Rösler and 28 more - JAMA Oncology 2021 cited by 354

  7. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 540

  8. Corrections to “Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

    Authors: , , , , , , - Annals of Oncology 2018 cited by 466

  9. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 724

  10. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Clinical Oncology 2021 cited by 244

  11. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2012 cited by 700

  12. ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma

    Authors: , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2020 cited by 92

  13. Future direction of total neoadjuvant therapy for locally advanced rectal cancer

    Authors: , , , , , , , , , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2024 cited by 73

  14. Outcome measures in multimodal rectal cancer trials

    Authors: , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 104

  15. Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review

    Authors: , , , , - Radiation Oncology 2020 cited by 78

  16. Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 1,221

  17. A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Scientific Reports 2017 cited by 229

  18. Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 457

  19. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

    Authors: , , , , , , , , , , , , , - European Journal of Nutrition 2021 cited by 54

  20. Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 609

  21. Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review

    Authors: , , , , , , , , , , - European Urology 2014 cited by 358

  22. Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials

    Authors: , , , , , , , , , , , , , - Radiotherapy and Oncology 2020 cited by 92

  23. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2020 cited by 67

  24. Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions

    Authors: , , , , - Cancers 2021 cited by 46